Cargando…
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Doxorubicin (DOX) is a chemotherapeutic drug widely used for cancer treatment, but its use is limited by cardiotoxicity. Although free radicals from redox cycling and free cellular iron have been predominant as the suggested primary pathogenic mechanism, novel evidence has pointed to topoisomerase I...
Autores principales: | Kawano, Ippei, Adamcova, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720152/ https://www.ncbi.nlm.nih.gov/pubmed/36479202 http://dx.doi.org/10.3389/fphar.2022.1055911 |
Ejemplares similares
-
The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
por: Adamcova, Michaela, et al.
Publicado: (2021) -
Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs
por: Adamcova, Michaela, et al.
Publicado: (2019) -
Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023) -
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
por: Kuang, Ziyu, et al.
Publicado: (2023) -
Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients
por: Ruggeri, Clarissa, et al.
Publicado: (2017)